Pesquisar
Charles River Laboratories International Inc
CRLAdicionar à lista de desejos
278.260USD
+5.260+1.93%
Fechamento 09-11 16:00（ET）
13.28BValor de mercado
PerdaP/L TTM
Após o expediente 19:00 (ET)278.260USD+0.300+0.11%
Após o expediente 19:00 (ET)Mais detalhes de Charles River Laboratories International Inc Empresa
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Charles River Laboratories International Inc Perfil
Código da empresaCRL
Nome da EmpresaCharles River Laboratories International Inc
Data de listagemJun 23, 2000
CEOFoster (James C)
Número de funcionários18600
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 23
Endereço251 Ballardvale St
CidadeWILMINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal01887
Telefone17812226000
Sitehttps://www.criver.com/
Código da empresaCRL
Data de listagemJun 23, 2000
CEOFoster (James C)
Executivos da empresa Charles River Laboratories International Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Executive Officer
Chief Executive Officer
58.26K
-0.91%
Mr. Glenn G. Coleman
Mr. Glenn G. Coleman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
27.75K
--
Mr. James C. Foster
Mr. James C. Foster
Non-Executive Director
Non-Executive Director
26.98K
--
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
--
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.47K
-1.78%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
5.67K
-88.92%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
4.56K
+43.24%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
3.85K
+37.34%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
2.38K
+60.32%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Executive Officer
Chief Executive Officer
58.26K
-0.91%
Mr. Glenn G. Coleman
Mr. Glenn G. Coleman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
27.75K
--
Mr. James C. Foster
Mr. James C. Foster
Non-Executive Director
Non-Executive Director
26.98K
--
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
20.94K
--
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
14.47K
-1.78%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
6.35K
+22.65%
Perguntas frequentes
Quem são os cinco principais acionistas de Charles River Laboratories International Inc?
Os cinco principais acionistas de Charles River Laboratories International Inc são: Ms. Birgit Girshick
Quantas instituições possuem ações da Charles River Laboratories International Inc (CRL)?
Em 2026Q1, 1429 instituições possuíam ações da Charles River Laboratories International Inc, com valor de mercado aproximado de 56.13M, representando 116.51% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -7963916.00.
Qual é a maior fonte de receita da Charles River Laboratories International Inc?
Em 2026Q1, o segmento de negócios DSA gerou a maior receita para Charles River Laboratories International Inc, totalizando 606.51M e representando 60.40% da receita total.